ATE491722T1 - Herstellung und reinigung von il-29 - Google Patents

Herstellung und reinigung von il-29

Info

Publication number
ATE491722T1
ATE491722T1 AT06816409T AT06816409T ATE491722T1 AT E491722 T1 ATE491722 T1 AT E491722T1 AT 06816409 T AT06816409 T AT 06816409T AT 06816409 T AT06816409 T AT 06816409T AT E491722 T1 ATE491722 T1 AT E491722T1
Authority
AT
Austria
Prior art keywords
methods
production
purification
coli
vectors
Prior art date
Application number
AT06816409T
Other languages
English (en)
Inventor
Bruce Zamost
Geoffrey Lee
Robert Dedinsky
Original Assignee
Zymogenetics L L C
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zymogenetics L L C, Bristol Myers Squibb Co filed Critical Zymogenetics L L C
Application granted granted Critical
Publication of ATE491722T1 publication Critical patent/ATE491722T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/02—Preparation of peptides or proteins having a known sequence of two or more amino acids, e.g. glutathione
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
AT06816409T 2005-10-04 2006-10-04 Herstellung und reinigung von il-29 ATE491722T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72354405P 2005-10-04 2005-10-04
PCT/US2006/039139 WO2007041713A1 (en) 2005-10-04 2006-10-04 Production and purification of il-29

Publications (1)

Publication Number Publication Date
ATE491722T1 true ATE491722T1 (de) 2011-01-15

Family

ID=37603659

Family Applications (1)

Application Number Title Priority Date Filing Date
AT06816409T ATE491722T1 (de) 2005-10-04 2006-10-04 Herstellung und reinigung von il-29

Country Status (15)

Country Link
US (6) US20080096252A1 (de)
EP (1) EP1931704B1 (de)
JP (3) JP5364375B2 (de)
AT (1) ATE491722T1 (de)
AU (1) AU2006299339B2 (de)
CA (1) CA2625208A1 (de)
CY (1) CY1112323T1 (de)
DE (1) DE602006018969D1 (de)
DK (1) DK1931704T3 (de)
ES (1) ES2357152T3 (de)
IL (2) IL189994A (de)
PL (1) PL1931704T3 (de)
PT (1) PT1931704E (de)
SI (1) SI1931704T1 (de)
WO (1) WO2007041713A1 (de)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE516820T1 (de) 2000-09-29 2011-08-15 Schering Corp Pegyliertes interleukin 10
US7038032B2 (en) 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
EP2251352A1 (de) * 2003-08-07 2010-11-17 ZymoGenetics, L.L.C. Homogene Präparate von IL-28 und IL-29
AU2006269908A1 (en) * 2005-07-20 2007-01-25 Bristol-Myers Squibb Company IL28 and IL29 truncated cysteine mutants and antiviral methods of using same
CA2616004A1 (en) * 2005-07-20 2007-02-01 Zymogenetics, Inc. Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
DK1931704T3 (da) 2005-10-04 2011-03-14 Zymogenetics L L C Frembringelse og rensning af IL-29
AR067537A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Purificacion de polipeptidos pegilados
AR067536A1 (es) 2007-07-17 2009-10-14 Hoffmann La Roche Metodo para obtener una eritropoyetina mono-pegilada en una forma sustancialmente homogenea
US9051369B2 (en) 2007-09-20 2015-06-09 Commonwealth Scientific And Industrial Research Organisation Avian cytokines and genetic sequences encoding same
AU2009204998B2 (en) 2008-01-18 2014-03-27 F. Hoffmann-La Roche Ag Purification of non-glycosylated proteins
JP2011522834A (ja) * 2008-06-05 2011-08-04 ザイモジェネティクス リミテッド ライアビリティ カンパニー Ｃ型肝炎の治療のためのペグ化ｉｉｉ型インターフェロンの使用
CA2742817A1 (en) 2008-11-20 2010-05-27 Biogen Idec Ma Inc. Arginine inactivation of viruses
DK2379115T3 (da) 2008-12-17 2018-01-29 Merck Sharp & Dohme Fremstilling og anvendelse af mono- og di-PEG-IL-10
BRPI1014952A2 (pt) * 2009-04-10 2019-09-24 Ls9 Inc "composição produzida por um microrganismo e composição de biocombustível."
US20120308517A1 (en) 2010-02-09 2012-12-06 Digna Biotech, S.L. Compositions for the treatment of infectious and tumoural diseases
JP5768341B2 (ja) * 2010-08-04 2015-08-26 東ソー株式会社 Ｆｃ結合性タンパク質の製造方法
CN102584979B (zh) * 2011-01-18 2015-10-14 北京凯因科技股份有限公司 PEG化干扰素λ
US10201584B1 (en) 2011-05-17 2019-02-12 Abbvie Inc. Compositions and methods for treating HCV
CA2846092A1 (en) * 2011-08-25 2013-02-28 Nanogen Pharmaceutical Biotechnology Peg-interferon lambda 1 conjugates
US8454947B1 (en) 2012-03-01 2013-06-04 Nanogen Pharmaceutical Biotechnology PEG-interferon lambda 1 conjugates
RU2549710C2 (ru) * 2012-06-29 2015-04-27 Федеральное государственное бюджетное учреждение "Государственный научный центр "Институт иммунологии" Федерального медико-биологического агентства (ФГБУ "ГНЦ Институт иммунологии" ФМБА России) Способ очистки рекомбинантного белка интерфероноподобного фактора iii типа
JP6086378B2 (ja) * 2012-11-30 2017-03-01 国立大学法人お茶の水女子大学 組み換えヒト膵臓リパーゼの調製方法
CN104045704B (zh) * 2013-03-11 2016-08-10 中国医学科学院基础医学研究所 PEG化重组人IFN-λ1、其制备方法和用途
CN105209054A (zh) 2013-04-18 2015-12-30 阿尔莫生物科技股份有限公司 使用白细胞介素-10治疗疾病和病症的方法
EP3434277A1 (de) 2013-06-17 2019-01-30 Armo Biosciences, Inc. Verfahren zur beurteilung der proteinidentität und -stabilität
US20160159853A1 (en) * 2013-07-19 2016-06-09 Biogenomics Limited Apparatus for refolding of recombinant proteins
AU2014311432A1 (en) 2013-08-30 2016-03-03 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
RU2016122957A (ru) 2013-11-11 2017-12-19 Армо Байосайенсиз, Инк. Способы применения интерлейкина-10 для лечения заболеваний и расстройств
EP3092248B1 (de) * 2014-01-08 2021-06-23 Prosit Sole Biotechnology (Beijing) Co. Ltd Fusionspolypeptide und verfahren zur verwendung
US11311519B2 (en) 2014-05-01 2022-04-26 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
US10076512B2 (en) 2014-05-01 2018-09-18 Eiger Biopharmaceuticals, Inc. Treatment of hepatitis delta virus infection
WO2015187295A2 (en) 2014-06-02 2015-12-10 Armo Biosciences, Inc. Methods of lowering serum cholesterol
CN107001438A (zh) 2014-10-14 2017-08-01 阿尔莫生物科技股份有限公司 白细胞介素‑15组合物及其用途
EP3209320B1 (de) 2014-10-22 2023-03-08 Armo Biosciences, Inc. Verfahren zur verwendung von interleukin-10 zur behandlung von erkrankungen und leiden
JP2018500341A (ja) * 2014-12-23 2018-01-11 アルモ・バイオサイエンシーズ・インコーポレイテッド 組み換えタンパク質の生産における収量改善法
WO2016126615A1 (en) 2015-02-03 2016-08-11 Armo Biosciences, Inc. Methods of using interleukin-10 for treating diseases and disorders
HUE054068T2 (hu) 2015-04-21 2021-08-30 Eiger Biopharmaceuticals Inc Lonafarnibot és Ritonavirt tartalmazó gyógyszerkészítmények
KR20180020141A (ko) 2015-05-28 2018-02-27 아르모 바이오사이언시스 인코포레이티드 암 치료에 사용되는 peg화된 인터류킨-10
CN108025040A (zh) 2015-08-25 2018-05-11 阿尔莫生物科技股份有限公司 使用白介素-10治疗疾病和病症的方法
PT3416675T (pt) 2016-02-19 2021-06-14 Eiger Biopharmaceuticals Inc Tratamento de infeção pelo vírus da hepatite delta com interferão lambda
TWI763732B (zh) * 2016-11-07 2022-05-11 美商西雅圖遺傳學公司 工程化半胱胺酸帽之分佈

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4795077A (en) * 1988-05-23 1989-01-03 Motorola Inc. Bonding method and apparatus
EP0626448A3 (de) 1993-05-26 1998-01-14 BOEHRINGER INGELHEIM INTERNATIONAL GmbH Verfahren zur Herstellung und Reinigung von alpha-Interferon
AU2346900A (en) * 1998-11-30 2000-06-19 Eli Lilly And Company Erythropoietic compounds
CZ299516B6 (cs) * 1999-07-02 2008-08-20 F. Hoffmann-La Roche Ag Konjugát erythropoetinového glykoproteinu, zpusobjeho výroby a použití a farmaceutická kompozice sjeho obsahem
AU2001271786A1 (en) * 2000-06-30 2002-01-14 Zymogenetics Inc. Interferon-like protein zcyto21
US7038032B2 (en) * 2001-04-20 2006-05-02 Zymogenetics, Inc. Cytokine protein family
WO2004037995A2 (en) * 2002-10-23 2004-05-06 Zymogenetics, Inc. Methods for treating viral infection using il-28 and il-29
MXPA05006117A (es) * 2002-12-13 2005-09-30 Zymogenetics Inc Produccion de il-21 en hospederos procarioticos.
EP2251352A1 (de) * 2003-08-07 2010-11-17 ZymoGenetics, L.L.C. Homogene Präparate von IL-28 und IL-29
AU2005231476B2 (en) 2004-04-02 2011-09-01 Zymogenetics, Inc. Il-28 and il-29 cysteine mutants for treating viral infection
CA2574564C (en) * 2004-07-29 2013-04-16 Zymogenetics, Inc. Use of il-28 and il-29 to treat cancer and autoimmune disorders
CN1305902C (zh) * 2004-11-25 2007-03-21 汕头大学医学院 一种人白细胞介素29的生产方法及重组il－29工程菌
DK1828239T3 (da) * 2004-12-10 2011-12-19 Zymogenetics Inc FGF18-produktion i prokaryote værter
CA2616004A1 (en) * 2005-07-20 2007-02-01 Zymogenetics, Inc. Use of truncated cysteine il28 and il29 mutants to treat cancers and autoimmune disorders
DK1931704T3 (da) * 2005-10-04 2011-03-14 Zymogenetics L L C Frembringelse og rensning af IL-29

Also Published As

Publication number Publication date
SI1931704T1 (sl) 2011-04-29
AU2006299339A1 (en) 2007-04-12
US20080096252A1 (en) 2008-04-24
JP2009510173A (ja) 2009-03-12
PT1931704E (pt) 2011-03-28
DE602006018969D1 (de) 2011-01-27
JP2013099337A (ja) 2013-05-23
IL189994A (en) 2013-08-29
WO2007041713A1 (en) 2007-04-12
CA2625208A1 (en) 2007-04-12
EP1931704A1 (de) 2008-06-18
US20100222552A1 (en) 2010-09-02
JP5364375B2 (ja) 2013-12-11
DK1931704T3 (da) 2011-03-14
US20120271037A1 (en) 2012-10-25
US7968315B2 (en) 2011-06-28
PL1931704T3 (pl) 2011-06-30
CY1112323T1 (el) 2015-12-09
US20130143270A1 (en) 2013-06-06
JP2012235789A (ja) 2012-12-06
IL189994A0 (en) 2008-08-07
ES2357152T3 (es) 2011-04-19
US7759092B2 (en) 2010-07-20
US20120015403A1 (en) 2012-01-19
US8211670B2 (en) 2012-07-03
EP1931704B1 (de) 2010-12-15
US8759027B2 (en) 2014-06-24
IL227691A0 (en) 2013-09-30
AU2006299339B2 (en) 2012-03-15
US20100003722A1 (en) 2010-01-07

Similar Documents

Publication Publication Date Title
ATE491722T1 (de) Herstellung und reinigung von il-29
DE602006019050D1 (de) Polypeptide mit cellobiohydrolaseaktivität und dafür kodierende polynukleotide
CY1110860T1 (el) Αναστροφη μεταγραφαση τελομερασης πτηνου
ATE515568T1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
ATE470702T1 (de) Verfahren zur herstellung von permanenten humanen zelllinien
EA201300054A1 (ru) Полипептид, обладающий активностью бета-глюкозидазы, и его применение
BRPI0613770A2 (pt) anticorpos anti-cd26 e métodos de uso destes
WO2011150133A3 (en) Fibronectin based scaffold proteins having improved stability
MX2009012846A (es) Polipeptidos que tienen actividad celulosica mejorada y polinucleotidos que los codifican.
DE69942459D1 (de) Isolierte nukleinsäuremoleküle die t-zellen induzierbare faktoren kodieren (tif), kodierte proteine und ihre anwendung
WO2010099477A3 (en) Polypeptide structural motifs associated with cell signaling activity
ATE513907T1 (de) Polypeptide mit endoglucanase-aktivität und polynukleotide zu ihrer kodierung
SG10201407329RA (en) Modified vasoactive intestinal peptides
TW200740841A (en) Polypeptides having antimicrobial activity and polynucleotides encoding same
BR112012008054A2 (pt) domínios catalíticos de lisil oxidase e loxl2
FI3581650T3 (fi) IX-tekijän polypeptidimutantti, sen käyttöjä ja menetelmä sen valmistamiseksi
BRPI0515904A (pt) processo para purificar uma mistura gasosa compreendendo monóxido de dinitrogênio, uso de uma mistura gasosa, e, processo para preparar uma cetona
BR112013003522A8 (pt) "polipeptídeos relaxina modificados compreendendo um aminoácido não codificado naturalmente, uso, método de preparação, bem como ácido nucleico codificando os mesmos"
ATE447013T1 (de) Polypeptide mit endoglucanase-aktivtät und dafür codierende polynukleotide
EA200701592A1 (ru) Композиты и способы их получения и использования
EA201300056A1 (ru) Полипептид с активностью ацетилксиланэстеразы и его применения
AR051489A1 (es) Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que los codifican
MX2008002485A (es) Polipeptidos que tienen actividad antimicrobiana y polinucleotidos que los codifican.
EA201300057A1 (ru) Полипептид, обладающий углеводдеградирующей активностью, и его применения
AU2003223124A1 (en) Polypeptide having an activity to support proliferation or survival of hematopoietic stem cell or hematopoietic progenitor cell, and dna coding for the same

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1931704

Country of ref document: EP